| Cat.No. | Name | Information |
|---|---|---|
| M53485 | HIV-1 gag Protein p24 (194-210) | HIV-1 gag Protein p24 (194-210) is a polypeptide that can be found by peptide screening. |
| M53484 | Pol (476-484), HIV-1 RT Epitope | Pol (476-484), HIV-1 RT Epitope is a biological active peptide. |
| M53482 | TAT (47-57) GGG-Cys(Npys) | TAT (47-57) GGG-Cys(Npys) is a cell-penetrating peptide (CPP). |
| M53481 | TAT (47-57), FAM-labeled | TAT (47-57), FAM-labeled is a cell-penetrating peptide (CPP). |
| M53480 | HBV Seq2 aa:179-186 | HBV Seq2 aa:179-186 serve as effective motifs for CTL response in H-2b system after in vitro restimulation of the primed T cells. |
| M53479 | HIV p17 Gag (77-85) | HIV p17 Gag (77-85) is an HLA-A*0201(A2)-restricted CTL epitope, used in the research of anti-HIV. |
| M53478 | H-Gly-Pro-Gly-NH2 | H-Gly-Pro-Gly-NH2 is a tripeptide that inhibits HIV-1 replication. |
| M53477 | HIV-1 Rev (34-50) | HIV-1 Rev (34-50) is a 17-aa peptide derived from the Rev-responsive element (RRE)-binding domains of Rev in HIV-1, with anti-HIV-1 activity. |
| M53476 | HIV-2 Peptide | HIV-2 Peptide is a polypeptide that can be found by peptide screening. |
| M53475 | Peptide T TFA | Peptide T (TFA) is an octapeptide from the V2 region of HIV-1 gp120. |
| M53474 | 2F5 epitope | 2F5 epitope, a peptide gp41 (659-671), comprises the entire epitope for one of the three known antibodies capable of neutralizing a broad spectrum of primary HIV-1 isolates and is the only such epitope that is sequential. |
| M53473 | Tifuvirtide | Tifuvirtide (T-1249) is a peptide human immunodeficiency virus type-1 (HIV-1) fusion inhibitor. |
| M53472 | Feglymycin | Feglymycin is a HIV replication inhibitor. |
| M53471 | Siamycin I | Siamycin I (BMY-29304), a 21-residue tricyclic peptide, is a secondary metabolite in actinomycetes. |
| M53470 | VIR-165 | VIR-165 is a modified form of virus inhibitory peptide (VIRIP) that binds the fusion peptide of the gp41 subunit and prevents its insertion into the target membrane. |
| M53469 | HEP-1 | HEP-1 (Human ezrin peptide (324-337)) is an orally active peptide with anti-HIV activity. |
| M53468 | Arg-Val-(Nle-p-nitro)-Phe-Glu-Ala-Nle-NH2 | Arg-Val-(Nle-p-nitro)-Phe-Glu-Ala-Nle-NH2 is a fluorogenic substrate of HIV-1 protease. |
| M53467 | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 | Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 is a substrato peptídico of HIV-1 protease. |
| M53466 | HIV-1, HIV-2 Protease Substrate | HIV-1, HIV-2 Protease Substrate is the substrate of HIV-1, HIV-2 protease. |
| M53465 | HIV Protease Substrate IV | HIV Protease Substrate IV is a substrate of HIV protease. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
